Both the companies are expected to establish a Product Advisory Committee to manage the activities that are required to develop and seek approval for PCV and to pursue World Health Organization (WHO) prequalification.
The tie up allows Merck to market PCV in some of the territories and Serum in other territories.
Under the contract, Merck and Serum will jointly contribute to the development and manufacture of PCV.